0000899243-22-004878.txt : 20220204 0000899243-22-004878.hdr.sgml : 20220204 20220204180932 ACCESSION NUMBER: 0000899243-22-004878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tessier Maude CENTRAL INDEX KEY: 0001848534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40287 FILM NUMBER: 22594965 MAIL ADDRESS: STREET 1: C/O IKENA ONCOLOGY, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ikena Oncology, Inc. CENTRAL INDEX KEY: 0001835579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-343-8292 MAIL ADDRESS: STREET 1: 50 NORTHERN AVE. CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-02 0 0001835579 Ikena Oncology, Inc. IKNA 0001848534 Tessier Maude C/O IKENA ONCOLOGY, INC. 645 SUMMER STREET, SUITE 101 BOSTON MA 02210 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 11.45 2022-02-02 4 A 0 40000 0.00 A 2032-02-02 Common Stock 40000 40000 D 25% of the shares subject to this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter. /s/ Douglas R. Carlson, as Attorney-in-Fact for Maude Tessier 2022-02-04